(Q54200559)

26 May 2018

review article

1 reference

title

Beta-lactamases: current situation and clinical importance. (English)

1 reference

26 May 2018

author name string

J Garau

series ordinal

1

1 reference

26 May 2018

publication date

1 July 1994

1 reference

26 May 2018

published in

Intensive Care Medicine

1 reference

26 May 2018

volume

20 Suppl 3

1 reference

26 May 2018

page(s)

S5-9

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1007/bf01745244

exact match

0 references

cites work

Characterization of beta-lactamases

1 reference

https://api.crossref.org/works/10.1007%2FBF01745244

More extended-spectrum beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745244

Transferable imipenem resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745244

Moxalactam in nosocomial infections with Serratia marcescens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745244

Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745244

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

21 January 2018

1 reference

12 December 2020

Extended-spectrum beta-lactamases

1 reference

12 December 2020

Ceftazidime in the treatment of serious Pseudomonas aeruginosa sepsis

1 reference

12 December 2020

Moxalactam therapy for bacterial infections

1 reference

12 December 2020

Clinical consequences of development of resistance to third generation cephalosporins

1 reference

12 December 2020

Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins

1 reference

12 December 2020

Experience with cefsulodin therapy for lower respiratory tract infections caused by Pseudomonas aeruginosa in adults without cystic fibrosis or granulocytopenia

1 reference

12 December 2020

Mechanisms of bacterial resistance to antibiotics

1 reference

12 December 2020

Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients.

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

Emergence of resistance in gram-negative bacteria during therapy with expanded-spectrum cephalosporins

1 reference

12 December 2020

Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain.

1 reference

12 December 2020

Cephalosporins: rationale for clinical use.

1 reference

12 December 2020

Emergence of ceftriaxone-resistant strains of Pseudomonas aeruginosa in cystic fibrosis patients.

1 reference

12 December 2020

Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients

1 reference

12 December 2020

β-Lactamases and snsceptibility phenotypes to β-lactam antibiotics in Escherichia coli strains

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01745244

1 reference

26 May 2018

1 reference

26 May 2018